Health technology assessment challenges in assessing clinical and cost effectiveness of cell / gene therapies.
Who pays? Healthcare system determinants of funding/reimbursement paradigm.
Affordability: Pricing and budget impact challenges
Speaker
W. Neil Palmer
President & Principal Consultant PDCI Market Access Inc.
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.